- Home
- FISI vs FDMT Comparison
FISI vs FDMT Comparison
Compare FISI & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FISI | FDMT |
|---|---|---|
| Founded | 1817 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 757.7M | 695.3M |
| IPO Year | 1999 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FISI | FDMT |
|---|---|---|
| Price | $40.87 | $11.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | ★ $45.00 | $28.09 |
| AVG Volume (30 Days) | 82.9K | ★ 968.6K |
| Earning Date | 10-29-2026 | 11-09-2026 |
| Dividend Yield | ★ 3.15% | N/A |
| EPS Growth | ★ 231.27 | 18.79 |
| EPS | ★ 2.08 | N/A |
| Revenue | N/A | ★ $85,209,000.00 |
| Revenue This Year | $6.51 | N/A |
| Revenue Next Year | $4.63 | $55.65 |
| P/E Ratio | $19.53 | ★ N/A |
| Revenue Growth | N/A | ★ 230194.60 |
| 52 Week Low | $28.00 | $6.96 |
| 52 Week High | $42.97 | $16.93 |
Technical Indicators
Market Signals| Indicator | FISI | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 61.68 | 35.73 |
| Support Level | $39.65 | $8.43 |
| Resistance Level | $41.94 | $11.96 |
| Average True Range (ATR) | 0.79 | 0.85 |
| MACD | 0.27 | -0.18 |
| Stochastic Oscillator | 89.83 | 12.38 |
Price Performance
Historical ComparisonAbout FISI Financial Institutions Inc.
Financial Institutions Inc operates through its subsidiaries, providing full range of banking services to consumer, commercial and municipal customers in Western and Central New York, and commercial loans in the Mid-Atlantic region, through a loan production office in Ellicott City, Maryland. It offers a broad range of loans including commercial business and revolving lines of credit, commercial mortgages, equipment loans, residential mortgage loans and home equity loans and lines of credit, automobile loans and personal loans. It operates in single segment of Banking.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).